COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News

COPD graphic | Image Credit: Maks_Lab - stock.adobe.com
Systemic Immune Response Index Identified as Independent Risk Factor for COPD

March 23rd 2025

The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary disease (COPD).

sleeping baby in father's arms | Image Credit: BazziBa - stock.adobe.com
Low Birth Weight Linked to Increased COPD Risk

December 30th 2024

TOP 5 COPD articles of 2024 | Image Credit: Venngage
Top 5 Most-Read COPD Content of 2024

December 26th 2024

CHEST 2024 highlights | Image Credit: Venngage
ICYMI: Highlights From CHEST 2024

December 19th 2024

ATS 2024 highlights
ICYMI: Highlights From ATS 2024

December 16th 2024

Type 2 Inflammation: A Common Theme Among Several Chronic Diseases

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
Continuing Medical Education
View All
June 16th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

5 Things About e-Cigarettes
April 5th 2019

5 Things About e-Cigarettes

Wallace Stephens
E-cigarettes have become increasingly popular in the United States since their introduction in 2007. Reported use has dramatically increased among adults and, alarmingly, youths, as well. Sales of e-cigarettes, other vaping devices, and e-liquids have increased nearly 1400% over the last decade.
Does Insurance Status Affect Hospital Care for Pulmonary Patients?
April 2nd 2019

Does Insurance Status Affect Hospital Care for Pulmonary Patients?

Wallace Stephens
Insurance status was found to potentially affect whether patients who used emergency department services were transferred to other hospitals, discharged, or admitted to hospitals.
Integrated Disease Management Improves Clinical Outcomes, QOL in Patients With COPD in Primary Care
April 1st 2019

Integrated Disease Management Improves Clinical Outcomes, QOL in Patients With COPD in Primary Care

Jaime Rosenberg
By providing case management, self-management education, and skills training, integrated disease management is associated with fewer exacerbations and improved quality of life (QOL) among patients with chronic obstructive pulmonary disease (COPD) enagaged in primary care.
Lung Function Improved as Patients Increased Strenuous Daily Physical Activity, Study Says
March 27th 2019

Lung Function Improved as Patients Increased Strenuous Daily Physical Activity, Study Says

Wallace Stephens
Individuals with an obstructive lung disease saw improvement in lung function when they replaced 30 minutes of sedentary time per day with strenuous or strength-building physical activity.
Can Telemonitoring Services Improve COPD Outcomes?
March 25th 2019

Can Telemonitoring Services Improve COPD Outcomes?

Jaime Rosenberg
A review of studies assessing the impact of telemonitoring on chronic obstructive pulmonary disease (COPD) outcomes resulted in mixed findings.
Adherence to COPD Treatment Lower With 3 Inhalers Compared With 2
March 20th 2019

Adherence to COPD Treatment Lower With 3 Inhalers Compared With 2

Jaime Rosenberg
Patients with chronic obstructive pulmonary disease (COPD) had lower medication adherence when taking 3 inhalers compared with 2, suggesting that reducing the number of inhalers for these patients may improve adherence.
COPD Symptoms Improved in Case Study of Endobronchial Valve Treatment
March 19th 2019

COPD Symptoms Improved in Case Study of Endobronchial Valve Treatment

Wallace Stephens
Symptoms of dyspnea in a patient with chronic obstructive pulmonary disease (COPD), which were caused by pulmonary hyperinflation, were improved by endobronchial valve treatment.
COPD Has Significant Impact on Biologic Aging
March 15th 2019

COPD Has Significant Impact on Biologic Aging

Jaime Rosenberg
Based on dehydroepiandrosterone and growth hormone levels, researchers have determined that chronic obstructive pulmonary disease (COPD) is associated with increased biological age.
Damage to Dwellings and How You Cleaned Up Affected Respiratory Health After 9/11
March 14th 2019

Damage to Dwellings and How You Cleaned Up Affected Respiratory Health After 9/11

Wallace Stephens
Exposure to dust from the collapse of the World Trade Center has been associated with a multitude of respiratory outcomes. For the first time, researchers looked at how dwellings in Lower Manhattan were damaged, how they were repaired, how people cleaned up afterwards, and how these differences affected the likelihood of respiratory symptoms and diseases.
e-Cigarettes Boost Heart Attack Risk, Emotional Stress, Findings Show
March 7th 2019

e-Cigarettes Boost Heart Attack Risk, Emotional Stress, Findings Show

Wallace Stephens
Those who use e-cigarettes face higher risks of having a heart attack, experiencing emotional distress, and developing coronary artery disease compared to non-users, according to an abstract to be presented at the upcoming American College of Cardiology Scientific Sessions and Exposition in New Orleans, Louisiana.
Investigating Annual Variation in Exacerbation Frequency in Patients With COPD
March 6th 2019

Investigating Annual Variation in Exacerbation Frequency in Patients With COPD

Wallace Stephens
Analysis of a 2-year study showed that fluctuations in yearly chronic obstructive pulmonary disease (COPD) exacerbation rates may be associated with variations in Haemophilus influenzae colonization.
Exhaled Breath Condensate Containing Ultrafine Particles Marks COPD Damage
March 2nd 2019

Exhaled Breath Condensate Containing Ultrafine Particles Marks COPD Damage

AJMC Staff
A recent study measured exhaled breath condensate (EBC) content that contained ultrafine particles (UFP) as a reflection of inflammation and oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and as a marker of exacerbations.
Spreading Awareness of the Risk of Lung Cancer in Patients with COPD
March 1st 2019

Spreading Awareness of the Risk of Lung Cancer in Patients with COPD

Wallace Stephens
The vast majority of patients with COPD require greater motivation to seek help when symptom changes occur and are unaware of their increased risk of developing lung cancer, according to new research.
Examining the Relationship Between Exacerbations and Decline in Physical Activity in Patients With COPD
February 23rd 2019

Examining the Relationship Between Exacerbations and Decline in Physical Activity in Patients With COPD

Wallace Stephens
There is no significant evidence to suggest that acute exacerbations of chronic obstructive pulmonary disease (COPD) cause an overall decline in patients’ physical activity over time, according to a new longitudinal study.
Costs for Patients With Alpha-1 Antitrypsin Form of COPD Are Higher, Study Says
February 21st 2019

Costs for Patients With Alpha-1 Antitrypsin Form of COPD Are Higher, Study Says

Allison Inserro
Researchers examined the medical costs for patients with a rare subset of chronic obstructive pulmonary disease (COPD) caused by a deficiency in alpha-1 antitrypsin receiving augmentation therapy.
Adding COPD Screenings to Drug Clinic Appointments Yields Benefits for Patients
February 15th 2019

Adding COPD Screenings to Drug Clinic Appointments Yields Benefits for Patients

Allison Inserro
A UK study found that adding respiratory health screenings to drug clinic appointments for those trying to recover from heroin use was effective at uncovering chronic obstructive pulmonary disease (COPD) in this group of patients.
Investigating Manual Therapy as a Treatment for COPD
February 14th 2019

Investigating Manual Therapy as a Treatment for COPD

Wallace Stephens
There is not enough evidence that manual therapy—a clinical approach of using skilled, physical, hands-on procedures to improve function, lessen pain, and facilitate movement—can successfully be used to treat chronic obstructive pulmonary disease (COPD).
Community-Acquired Pneumonia Presents Burden for Patients With COPD
February 9th 2019

Community-Acquired Pneumonia Presents Burden for Patients With COPD

Allison Inserro
A survey of patients with chronic obstructive pulmonary disease (COPD) who had contracted community-acquired pneumonia showed that the additional illness caused a significant burden, such as lost time from work, as well as a burden on their caregivers.
COPD Workshop Finds Deficiencies in Efforts to Cut Hospital Readmissions
February 9th 2019

COPD Workshop Finds Deficiencies in Efforts to Cut Hospital Readmissions

Allison Inserro
Six areas that need improvement emerged from a workshop examining best practices and models to reduce hospital readmissions in patients with chronic obstructive pulmonary disease (COPD).
Long-Term Use of Statins Reduces Mortality, Inflammation in COPD, Review Says
January 31st 2019

Long-Term Use of Statins Reduces Mortality, Inflammation in COPD, Review Says

Allison Inserro
A recent review showed that the long-term use of statins reduced the risk of acute exacerbation in chronic obstructive pulmonary disease (COPD), heart disease–related mortality and all-cause mortality, as well as decreased inflammatory factors.
Study Tests Whether Asthma–COPD Overlap Is a Heterogeneous Condition
January 30th 2019

Study Tests Whether Asthma–COPD Overlap Is a Heterogeneous Condition

Allison Inserro
Asthma–COPD overlap (ACO) is a term that encompasses patients with characteristics of 2 conditions, asthma and chronic obstructive pulmonary disease (COPD). A recent study from Spain sought to validate a proposed algorithm to help clinicians identify ACO among patients with COPD, in an effort to tailor treatment.
Phase 4 Study of Formoterol Fumarate Finds Safety Outcomes Similar to Placebo
January 26th 2019

Phase 4 Study of Formoterol Fumarate Finds Safety Outcomes Similar to Placebo

AJMC Staff
A phase 4 study of formoterol fumarate showed similar safety performance as placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, according to a recently published study.
Adding Exercise to COPD Treatment Is Cost-Effective, Simulation Study Says
January 22nd 2019

Adding Exercise to COPD Treatment Is Cost-Effective, Simulation Study Says

Allison Inserro
Researchers in the United Kingdom used a Markov microsimulation model comparing a population with chronic obstructive pulmonary disease (COPD) performing physical activity vs a COPD population that was sedentary, in order to estimate the cost-effectiveness of regular PA vs a sedentary lifestyle.
Poor Nutritional Status Affects Quality of Life for Patients With COPD
January 19th 2019

Poor Nutritional Status Affects Quality of Life for Patients With COPD

Allison Inserro
A recent study examined the nutritional status and dietary intake among outpatients with chronic obstructive pulmonary disease (COPD) and its possible associations with quality of life.
Researchers Document Links Between Pollution Levels, ED Visits for Breathing Problems
January 19th 2019

Researchers Document Links Between Pollution Levels, ED Visits for Breathing Problems

Allison Inserro
Researchers investigating the associations between ground-level ozone and fine particulate pollution and emergency department (ED) visits for chronic obstructive pulmonary disease, asthma, and respiratory infections found that as levels rose, more patients land in the ED with breathing problems.
Researchers Say They've Found Tiny Extracellular Entity That Causes COPD Damage
January 15th 2019

Researchers Say They've Found Tiny Extracellular Entity That Causes COPD Damage

AJMC Staff
Researchers said they found a previously unreported pathogenic entity that links chronic inflammation and tissue destruction in the lungs of patients with chronic obstructive pulmonary disease (COPD).
Severe Dyspnea Influences COPD Treatment Response, Confirms Benefit of Combination Therapy
January 9th 2019

Severe Dyspnea Influences COPD Treatment Response, Confirms Benefit of Combination Therapy

Allison Inserro
When to begin maintenance therapy for patients with chronic obstructive pulmonary disease (COPD) with either a single drug, or a combination of long-acting bronchodilators, is not always clear. A new study looking at whether baseline symptomatic status influences response to treatment suggests that patients with more severe dyspnea benefit more from a combination of tiotropium/olodaterol than tiotropium alone.
ResMed Highlights Digital Health at JP Morgan Conference
January 8th 2019

ResMed Highlights Digital Health at JP Morgan Conference

Allison Inserro
Chronic obstructive pulmonary disease is one of the world’s top drivers of chronic disease burdens, the chief executive officer of ResMed told the JP Morgan Healthcare Conference, as he explained the company’s strategy to help meet unmet needs using digital connectivity and data analytics.
COPD Exacerbations Tied to Increased Risks for Patients Who Also Have CAD
January 5th 2019

COPD Exacerbations Tied to Increased Risks for Patients Who Also Have CAD

Allison Inserro
A recent study looking at the impact of recent exacerbations of chronic obstructive pulmonary disease (COPD) on hospitalized patients who also have coronary artery disease (CAD) found that COPD was was independently associated with additional risks of complications after percutaneous coronary intervention.
Vaccination Cuts Risk of Severe Flu in Hospitalized Patients With COPD
January 5th 2019

Vaccination Cuts Risk of Severe Flu in Hospitalized Patients With COPD

Allison Inserro
Hospitalized patients with chronic obstructive pulmonary disease (COPD) who tested positive for the flu and were unvaccinated had worse death rates and more severe illness than those who were vaccinated, according to a recent study.
<1
...
131415161718192021
...
26>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo